OverviewSuggest Edit

Veru Inc. (formerly known as The Female Health Company) is a medical therapeutics company, with an initial focus on the development and commercialization of pharmaceuticals for men’s and women’s health and oncology. The Company manages the Pharmaceuticals Division, which develops and commercializes pharmaceutical products for men's and women's health and oncology; and the Consumer Health and Medical Devices Division, which is focused on commercializing sexual healthcare products and devices for the consumer market, including the Company’s Female Condom for over-the-counter, and as the Female Disposable Contraceptive Device, as well as PREBOOST (benzocaine 4%) medicated individual wipes which is a male genital desensitizing drug product that helps in the prevention of premature ejaculation.
TypePublic
Founded1896
HQMiami, US
Websiteveruhealthcare.com
Employee Ratings5

Latest Updates

Employees (est.) (Feb 2019)171(-2%)
Revenue (FY, 2018)$15.9 M(+17%)

Veru Office Locations

Veru has an office in Miami
Miami, US (HQ)
4400 Biscayne Blvd #888
Show all (1)
Report incorrect company information

Veru Financials and Metrics

Veru Revenue

Veru's revenue was reported to be $15.86 m in FY, 2018
USD

Revenue (Q1, 2019)

6.4m

Gross profit (Q1, 2019)

4.6m

Gross profit margin (Q1, 2019), %

72.9%

Net income (Q1, 2019)

(2.1m)

EBIT (Q1, 2019)

(1.0m)

Market capitalization (31-Aug-2018)

105.8m

Cash (31-Dec-2018)

9.0m
Veru's current market capitalization is $105.8 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

31.5m24.5m32.6m22.1m13.7m15.9m

Revenue growth, %

(32%)

Cost of goods sold

14.0m11.4m13.6m8.8m6.6m7.1m

Gross profit

17.5m13.1m19.0m13.3m7.0m8.8m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

6.7m4.3m7.9m6.7m11.0m7.8m8.2m4.8m5.6m3.2m2.4m4.3m2.6m2.6m5.5m6.4m

Cost of goods sold

3.0m2.0m3.7m2.8m4.6m3.2m2.8m1.9m2.3m1.6m1.1m2.0m1.3m1.4m2.4m1.7m

Gross profit

3.7m2.4m4.2m3.8m6.4m4.6m5.4m2.8m3.2m1.7m1.3m2.3m1.3m1.2m3.1m4.6m

Gross profit Margin, %

55%55%53%57%58%59%66%60%58%51%53%53%51%47%56%73%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

8.9m5.8m4.1m2.4m3.3m3.8m

Accounts Receivable

4.0m

Inventories

2.5m3.0m1.7m2.5m2.8m2.3m

Current Assets

16.9m13.1m21.6m18.3m10.3m11.2m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

8.0m5.9m4.1m4.6m2.9m2.6m3.7m2.8m3.2m3.5m1.2m2.7m3.6m9.0m5.6m9.0m

Accounts Receivable

2.7m2.5m5.4m5.8m12.5m14.3m17.7m18.6m18.6m8.4m7.3m5.8m3.0m3.0m3.7m2.5m

Inventories

2.5m4.1m3.0m3.5m2.8m2.5m1.6m2.2m2.3m2.5m2.5m2.8m3.1m3.6m2.7m2.7m

Current Assets

16.3m15.1m14.7m14.5m19.3m20.9m23.5m24.2m25.0m15.1m11.7m12.0m10.3m16.2m12.9m15.4m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

14.3m2.4m4.3m344.7k(6.6m)

Depreciation and Amortization

556.3k589.3k494.3k422.9k334.0k176.8k

Inventories

(994.6k)(561.6k)1.1m(738.8k)(479.4k)375.0k

Accounts Payable

(871.3k)220.8k(47.5k)(376.3k)897.5k496.0k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

1.5m1.8m3.0m804.9k1.7m3.6m1.5m1.5m2.1m(1.4m)(3.1m)(3.9m)(4.3m)(8.1m)(16.0m)(2.1m)

Depreciation and Amortization

143.7k286.9k429.2k372.5k114.4k226.7k327.6k89.3k177.4k267.2k44.2k88.2k131.9k42.6k

Inventories

111.4k95.4k(131.7k)(299.1k)(821.1k)114.0k

Accounts Payable

1.2m1.2m1.5m931.3k1.1m1.0m1.1m(522.1k)(353.2k)127.5k853.9k775.9k
USDY, 2018

Revenue/Employee

36.4k

Financial Leverage

1.4 x
Show all financial metrics
Report incorrect company information

Veru Online and Social Media Presence

Embed Graph
Report incorrect company information

Veru News and Updates

Veru Reports Strong Fiscal 2019 First Quarter Financial Results

    -- Drug Development Advancing: Successful TADFIN Clinical Trial with NDA Filing in 2019; Two Prostate Cancer Clinical Trials Enrolling -- -- Company to Host Investor Conference Call on Wednesday, February 13, 2019, 8 a.m. ET --

Veru to Report Fiscal 2019 First-Quarter Financial Results, Host Conference Call on February 13th

MIAMI, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for the prostate cancer continuum of care and urology specialty pharmaceuticals, today announced that on Wednesday, February 13, 2019, the Company will re…

Veru Reports Strong Net Revenues and Gross Profit for Fiscal 2018 Fourth-Quarter

-- Advancing Multiple Drug Candidates, Two Drugs Currently in Clinical Trials, Company Transforming into Biopharmaceutical with Focus on Prostate Cancer, Successfully Completes Stock Offering, Awarded Large FC2 Tender -- Company to Host Investor Conference Call on Thursday, December 1…

Veru to Report Fiscal Year 2018 Financial Results, Host Conference Call on December 13th

MIAMI, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that on Thursday, December 13, 2018, the company will report financial results for the fourth quarter and fiscal year ended September 30, 2018, before the market op…

Veru to Present at Upcoming Healthcare Investor Conferences in New York

MIAMI, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that the company’s Chairman, President and Chief Executive Officer, Dr. Mitchell Steiner, will present an overview of the company’s development programs at the fol…
Show more
Report incorrect company information

Veru Frequently Asked Questions

  • When was Veru founded?

    Veru was founded in 1896.

  • How many employees does Veru have?

    Veru has 171 employees.

  • What is Veru revenue?

    Latest Veru annual revenue is $15.9 m.

  • What is Veru revenue per employee?

    Latest Veru revenue per employee is $92.8 k.

  • Who are Veru competitors?

    Competitors of Veru include Sensus Healthcare, Eckert & Ziegler and Photocure.

  • Where is Veru headquarters?

    Veru headquarters is located at 4400 Biscayne Blvd #888, Miami.

  • Where are Veru offices?

    Veru has an office in Miami.

  • How many offices does Veru have?

    Veru has 1 office.